Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
Open Access
- 1 December 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (68) , 112893-112906
Abstract
Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancerKeywords
This publication has 48 references indexed in Scilit:
- Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cellsCancer Letters, 2013
- Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditionsRadiotherapy and Oncology, 2013
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisMolecular Cell, 2011
- Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS MutationsCancer Research, 2009
- ATM and Artemis promote homologous recombination of radiation‐induced DNA double‐strand breaks in G2The EMBO Journal, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in GlioblastomaCancer Research, 2009
- Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing RadiationJournal of Biological Chemistry, 2007
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- PI3K/Akt and apoptosis: size mattersOncogene, 2003